Advisor Group’s NEVRO CORP. NVRO Stock Holding History

Advisor Group’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$354K	Sell	3,015 -90	-3%	-$8.91K	﹤0.01%	1926
2019 Q3	$266K	Buy	3,105 +1,233	+66%	+$93.3K	﹤0.01%	2111
2019 Q2	$121K	Buy	1,872 +129	+7%	+$8.03K	﹤0.01%	2716
2019 Q1	$108K	Buy	1,743 +822	+89%	+$38.7K	﹤0.01%	2788
2018 Q4	$36K	Buy	921 +361	+64%	+$16K	﹤0.01%	3426
2018 Q3	$33K	Buy	560 +183	+49%	+$11.4K	﹤0.01%	3576
2018 Q2	$30K	Sell	377 -1	-0.3%	-$83	﹤0.01%	3463
2018 Q1	$33K	Sell	378 -1	-0.3%	-$81	﹤0.01%	3369
2017 Q4	$26K	Sell	379 -191	-34%	-$15.3K	﹤0.01%	3549
2017 Q3	$52K	Buy	570 +38	+7%	+$3.25K	﹤0.01%	2914
2017 Q2	$39K	Sell	532 -3,940	-88%	-$316K	﹤0.01%	3015
2017 Q1	$419K	Buy	4,472 +4,239	+1,819%	+$384K	0.01%	1172
2016 Q4	$17K	Buy	233 +15	+7%	+$1.28K	﹤0.01%	3330
2016 Q3	$23K	Sell	218 -4,192	-95%	-$379K	﹤0.01%	3070
2016 Q2	$325K	Buy	+4,410	New	+$299K	0.01%	1162

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Advisor Group's NVRO Position: Q4 2019 in Review

Advisor Group reduced its NEVRO CORP. (NVRO) stake by 2.9% in Q4 2019, selling an estimated $8.91K and leaving 3,015 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #1926.

Advisor Group first reported a position in NVRO in Q2 2016 and has held it in 15 quarters since. The position peaked at $419K in Q1 2017. 191 funds tracked by Wall St. Rank hold NVRO as of Q4 2019.

Advisor Group held 3,015 shares of NEVRO CORP. worth $354K as of Q4 2019.
Advisor Group sold 90 NEVRO CORP. shares in Q4 2019, an estimated $8.91K.
NEVRO CORP. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #1926 holding.
Advisor Group first reported a position in NEVRO CORP. in Q2 2016 and has held it in 15 quarters since.
Advisor Group's NEVRO CORP. position peaked at $419K in Q1 2017.
191 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.